March 28, 2018 /PRNewswire/ — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced today that the European Medicines Agency (EMA) has accepted BioMarin’s submission of a Marketing Authorization … from a page on the website of the European Society …
Your email address will not be published. Required fields are marked *